Efficacy and safety of indacaterol/glycopyrronium fixed-dose combination in mild-to-moderate COPD patients symptomatic on tiotropium in Korea: study protocol for a randomized controlled trial

BACKGROUND: Long-acting bronchodilator monotherapy (long-acting β(2)-agonist [LABA] or long-acting muscarinic antagonist [LAMA]) is extensively used for treatment of patients with chronic obstructive pulmonary disease (COPD) with mild-to-moderate airflow limitation. However, a substantial number of...

Descripción completa

Detalles Bibliográficos
Autores principales: Rhee, Chin Kook, Park, Hye Yun, Park, Jeong-Woong, Lee, Ji-Hyun, Kim, Tae-Hyung, Lee, Sei Won, Jung, Ji Ye, Kim, Song, Hwang, Yong Il, Jung, Ki-Suck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322667/
https://www.ncbi.nlm.nih.gov/pubmed/28228162
http://dx.doi.org/10.1186/s13063-017-1800-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322667/
https://www.ncbi.nlm.nih.gov/pubmed/28228162
http://dx.doi.org/10.1186/s13063-017-1800-3

Ejemplares similares